M. W. Merx, E. A. Liehn, U. Janssens, et al., “HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Modelo Os Sepsis,” Circulation, Vol. 109, No. 21, 2004, pp. 2560-2565.
http://dx.doi.org/10.1161/01.CIR.0000129774.09737.5B

has been cited by the following article:

• TITLE: Statins and Sepsis Literature Review

  AUTHORS: Alicia Hernández Torres, Ana Belén Hernández Cascales, Pedro Pujante Alarcón, Alfonso López Ruiz, María Ángeles Ibáñez Gil, María Dolores Hellín Gil

  KEYWORDS: Statins; Pravastatin; Simvastatin; Sepsis; Bacteremia; Mortality

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.4 No.8, November 8, 2013

  ABSTRACT: Recent data suggest that, in addition to improving dyslipidemia, statin may reduce the risk of infections and infection-related complications. The aim of this study is to make a review of the literature about the effects of statins on clinically relevant outcomes of patients admitted to the hospital and having an infection and/or sepsis, principally in terms of intensive care unit admissions and related death.